Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidi Lyng

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcomeErlend K F Andersen, Knut Håkon Hole, Kjersti V Lund, et al.
Acta Oncologica (Stockholm, Sweden)|March 19, 2025
Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: A phase II, randomized studyKjersti Skipar, Tord Hompland, Kjersti V Lund, et al.
Ebiomedicine|June 25, 2020
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneityChristina S Fjeldbo, Tord Hompland, Tiril Hillestad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancerCathinka Halle, Malin Lando, Debbie Hege Svendsrud, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Autodelineation of cervical cancers using multiparametric magnetic resonance imaging and machine learningTurid Torheim, Eirik Malinen, Knut Håkon Hole, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 13, 2021
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancerAndreas J Tulipan, Unn Beate Salberg, Knut Håkon Hole, et al.
Radiation Oncology (London, England)|May 25, 2012
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancerKathrine Røe, Lars Tg Mikalsen, Albert J van der Kogel, et al.
Plos Genetics|November 14, 2009
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancerMalin Lando, Marit Holden, Linn C Bergersen, et al.
BMC Genomics|October 24, 2006
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancerHeidi Lyng, Runar S Brøvig, Debbie H Svendsrud, et al.
International Journal of Cancer|June 29, 2004
Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervixHeidi Lyng, Marzieh Beigi, Debbie H Svendsrud, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2013
Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcomeErlend K F Andersen, Knut Håkon Hole, Kjersti V Lund, et al.
Acta Oncologica (Stockholm, Sweden)|March 19, 2025
Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: A phase II, randomized studyKjersti Skipar, Tord Hompland, Kjersti V Lund, et al.
Ebiomedicine|June 25, 2020
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneityChristina S Fjeldbo, Tord Hompland, Tiril Hillestad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2011
Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancerCathinka Halle, Malin Lando, Debbie Hege Svendsrud, et al.
Acta Oncologica (Stockholm, Sweden)|May 4, 2017
Autodelineation of cervical cancers using multiparametric magnetic resonance imaging and machine learningTurid Torheim, Eirik Malinen, Knut Håkon Hole, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 13, 2021
Amino acid transporter expression and 18F-FACBC uptake at PET in primary prostate cancerAndreas J Tulipan, Unn Beate Salberg, Knut Håkon Hole, et al.
Radiation Oncology (London, England)|May 25, 2012
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancerKathrine Røe, Lars Tg Mikalsen, Albert J van der Kogel, et al.
Plos Genetics|November 14, 2009
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancerMalin Lando, Marit Holden, Linn C Bergersen, et al.
BMC Genomics|October 24, 2006
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancerHeidi Lyng, Runar S Brøvig, Debbie H Svendsrud, et al.
International Journal of Cancer|June 29, 2004
Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervixHeidi Lyng, Marzieh Beigi, Debbie H Svendsrud, et al.
Pageof 7